Boston Scientific unveils drug-coated stent

05/19/2009 | Boston Globe (tiered subscription model), The

Boston Scientific has introduced in select global markets its TAXUS Element Paclitaxel-Eluting Coronary Stent System. The device uses platinum chromium alloy designed for coronary stent purposes and "represents the company's third-generation drug-eluting stent technology," Boston Scientific said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN